Prim, S.A.

MCE PRM.MC

Prim, S.A. EBITDA for the year ending December 31, 2023: USD 30.96 M

Prim, S.A. EBITDA is USD 30.96 M for the year ending December 31, 2023, a 46.80% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Prim, S.A. EBITDA for the year ending December 31, 2022 was USD 21.09 M, a -38.60% change year over year.
Prim, S.A. EBITDA for the year ending December 31, 2021 was USD 34.35 M, a 82.34% change year over year.
Prim, S.A. EBITDA for the year ending December 31, 2020 was USD 18.84 M, a -24.15% change year over year.
Prim, S.A. EBITDA for the year ending December 31, 2019 was USD 24.84 M, a -0.07% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

MCE: PRM.MC

Prim, S.A.

CEO	Mr. Pedro Prim
IPO Date	April 1, 2005
Location	Spain
Headquarters	Calle Yolanda GonzAlez, number 15
Employees	901
Sector	Healthcare
Industries Dental Care 3D Printing Biotechnology Hospitals & Clinics Leisure Medical Instruments Personal Care Robotics

Description

Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.

Key trends

Past 5 years